Harf C, Welter R
Centre Hospitalier of Luxembourg, Grand Duchy of Luxembourg, West Europe.
Am J Cardiol. 1988 Mar 25;61(9):22E-27E. doi: 10.1016/0002-9149(88)90085-9.
Intravenous isosorbide-5-mononitrate (IS-5-MN) was administered to 24 patients, mean age 73, with severe respiratory distress after pulmonary edema and acute left heart failure. The condition was due to ischemic cardiopathy in 18 patients (4 with acute myocardial infarctions), congestive cardiomyopathy in 3, hypertensive cardiopathy in 2, and mitral valvular disease in 1. Therapy consisted of an intravenous (i.v.) bolus dose of IS-5-MN, followed by a continuous infusion (mean 8 mg/hour over 24 hours) of i.v. furosemide and additional oxygen. Clinical data were recorded as well as blood gas values and repeated chest radiographs. All patients survived and improved markedly; only 6 needed mechanical ventilation. Most patients had fast respiratory relief, with no untoward reaction, except a brief decrease of blood pressure in a ventilated patient taking morphine. These data indicate that i.v. IS-5-MN is effective and safe for the management of severe acute cardiogenic pulmonary edema.
对24例平均年龄73岁、因肺水肿和急性左心衰竭而出现严重呼吸窘迫的患者静脉注射5-单硝酸异山梨酯(IS-5-MN)。其中18例患者病因是缺血性心脏病(4例为急性心肌梗死),3例为充血性心肌病,2例为高血压性心脏病,1例为二尖瓣疾病。治疗方法包括静脉推注IS-5-MN,随后持续静脉输注(24小时平均8毫克/小时)呋塞米并额外吸氧。记录临床数据以及血气值并重复拍摄胸部X光片。所有患者均存活且明显好转;只有6例需要机械通气。大多数患者呼吸迅速缓解,未出现不良反应,只有1例接受机械通气且正在使用吗啡的患者血压出现短暂下降。这些数据表明静脉注射IS-5-MN治疗严重急性心源性肺水肿有效且安全。